Latest News

09 Mar 2016 Atezolizumab in Patients With Locally Advanced and Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
08 Mar 2016 Working Towards Equality for Women in Oncology
08 Mar 2016 Launch of EMA’s Priority Medicines Scheme Bioethics, legal and economic issues
08 Mar 2016 ESMO Open Press Release: High White Blood Cell Ratio Linked to Recurrence Risk in Early Stage Breast Cancer Breast cancer
Webcasts
Webcasts
04 Mar 2016 ESMO is Proud That Charité Connects the Patient Guides to the Clinic’s Website
03 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Generic Palonosetron Palliative and supportive care
02 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Trifluridine/Tipiracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
01 Mar 2016 ESMO mourns the loss of Dr. Holbrook Kohrt
01 Mar 2016 EMA Recommends Extending Indications for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
29 Feb 2016 EMA Recommends Extending Indications for Afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Feb 2016 EMA Recommends Extending the Use of Nivolumab Genitourinary cancers - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
25 Feb 2016 US FDA Seeks Support for the National Cancer Moonshot Initiative Bioethics, legal and economic issues